|

Osimertinib + Chemotherapy Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Tagrisso, Cisplatin, Carboplatin, Pemetrexed

Top Sponsors

  • PrECOG, LLC.1

Indications

  • Epidermal Growth Factor Receptor Gene Mutation1
  • Stage IV Lung Cancer1
  • Stage III Lung Cancer1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1

Birmingham, Alabama1 trial

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

University of Alabama at Birmingham

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.